Halozyme Therapeutics, Inc. Financial and Investor Update

Company's Annual Report on Form 10-K for the year ended December 31, 2024 . This discussion may contain forward-looking statements based ...







Form 10-K for Metagenomi INC filed 03/27/2024 - Annual Reports
Regarding concerns about confounding conditions such as ocular, orbital, or periorbital tumors and related treatments like chemotherapy or ...
vTv Therapeutics Annual Report 2025 Form 10-K ... - StockLight
... Form 10-K. Available Information. We file Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, proxy.
8-K - Corbus Pharmaceuticals Holdings, Inc.
... Form 10-K. Other than an investor's own internet access charges, we ... Therapeutix, Inc., a biopharmaceutical company focused on the ...



Autres Cours:

Inside the Courts | An Update From Skadden Securities Litigators